Search by Drug Name or NDC

    NDC 62332-0052-30 Irbesartan and Hydrochlorothiazide 12.5; 300 mg/1; mg/1 Details

    Irbesartan and Hydrochlorothiazide 12.5; 300 mg/1; mg/1

    Irbesartan and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is HYDROCHLOROTHIAZIDE; IRBESARTAN.

    Product Information

    NDC 62332-0052
    Product ID 62332-052_a749e5f3-f0e7-41db-a3c6-ff6928d7f51f
    Associated GPIs 36994002300340
    GCN Sequence Number 041897
    GCN Sequence Number Description irbesartan/hydrochlorothiazide TABLET 300-12.5MG ORAL
    HIC3 A4I
    HIC3 Description ANGIOTENSIN RECEPTOR ANTAG.-THIAZIDE DIURETIC COMB
    GCN 11295
    HICL Sequence Number 018963
    HICL Sequence Number Description IRBESARTAN/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Irbesartan and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Irbesartan and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 300
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; IRBESARTAN
    Labeler Name Alembic Pharmaceuticals Inc.
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091370
    Listing Certified Through 2024-12-31

    Package

    NDC 62332-0052-30 (62332005230)

    NDC Package Code 62332-052-30
    Billing NDC 62332005230
    Package 30 TABLET in 1 BOTTLE (62332-052-30)
    Marketing Start Date 2016-05-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.23228
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description IRBESARTAN-HYDROCHLOROTHIAZIDE 300-12.5 MG TB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis